Assessment of Gastrointestinal Adverse Effects during the First Six Months of “Biktarvy” Antiretroviral Therapy: Age-Related Patterns and Their Relation with Changes of 5 kg Weight Loss/Gain in the Initial Treatment Period

Assessment of Gastrointestinal Adverse Effects during the First Six Months of “Biktarvy” Antiretroviral Therapy: Age-Related Patterns and Their Relation with Changes of 5 kg Weight Loss/Gain in the Initial Treatment Period

Background: The battle against HIV has led to the development of antiretroviral therapy (ART), including BIKTARVY<sup>®</sup>, which combines three potent agents. However, concerns about gastrointestinal side effects during the early phases of treatment have emerged, potentially impactin...

Full description

Bibliographic Details
Main Authors: Madalina-Ianca Suba, Simona-Alina Abu-Awwad, Ovidiu Rosca, Mirela-Mădălina Turaiche, Bogdan Hogea, Ahmed Abu-Awwad, Razvan Nitu, Voichita Elena Lazureanu
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Diseases
Subjects:
bictegravir
emtricitabine
tenofovir alafenamide
BIKTARVY<sup>®</sup>
antiretroviral therapy
HIV
Online Access:https://www.mdpi.com/2079-9721/12/1/3

Internet

https://www.mdpi.com/2079-9721/12/1/3

Similar Items